Illumina (NASDAQ:ILMN) Lowered to "Hold" Rating by Zacks Research

Lonza NewsAcetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com

Thermo FisherThermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory

10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0

Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia

IlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina

FierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises

FierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset

FierceBiotechRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials

Roche MediaRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech

Lonza NewsProject Hope Foundation receives $50K donation from Lonza Capsugel - Greenville Journal

Harvard BioscienceHarvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan

FierceBiotechPulnovo Medical scores $100M in finance round led by Medtronic